The latest closing stock price for NovoCure as of November 22, 2024 is 17.73.
An investor who bought $1,000 worth of NovoCure stock at the IPO in 2015 would have $-30 today, roughly 0 times their original investment - a -0.34% compound annual growth rate over 9 years.
The all-time high NovoCure stock closing price was 225.58 on June 23, 2021.
The NovoCure 52-week high stock price is 24.73, which is 39.5% above the current share price.
The NovoCure 52-week low stock price is 11.29, which is 36.3% below the current share price.
The average NovoCure stock price for the last 52 weeks is 16.42.
An investor who bought $1,000 worth of NovoCure stock at the IPO in 2015 would have $-30 today, roughly 0 times their original investment - a -0.34% compound annual growth rate over 9 years.
The all-time high NovoCure stock closing price was 225.58 on June 23, 2021.
The NovoCure 52-week high stock price is 24.73, which is 39.5% above the current share price.
The NovoCure 52-week low stock price is 11.29, which is 36.3% below the current share price.
The average NovoCure stock price for the last 52 weeks is 16.42.